Washington, DC (February 23, 2017) Erik Mollo-Christensen, AIA, an international expert in planning and design of proton therapy centers has joined Stantec as a senior architect.

Based in the firm’s Washington, DC office, Mollo-Christensen has a key role in the firm’s Particle Therapy Center of Excellence, an international practice dedicated to the highly specialized field of particle therapy in cancer treatment programs. With expertise in lab and vivarium planning, Mollo-Christensen will also support the firm’s science and technology practice.

For more than 25 years, Mollo-Christensen has led project teams in planning, design, and construction administration for dozens of radiotherapy and cancer center facilities. His experience ranges from one room to multi-room proton therapy centers, including a 1.2 million-square-foot cancer center with a two-level integrated radiotherapy department, featuring five particle therapy and 17 radiation therapy treatment rooms, as well as 100,000 square feet of translational research labs.


The advent of proton therapy has significantly enhanced and extended the field of radiation oncology. Mollo-Christensen has been at the forefront of designing for new frontiers in particle therapy. These include hadron therapy, which relies on beams of charged particles (including protons) and heavier ions (including carbon) to improve cancer cure rates.

At Stantec, a dedicated team of medical planers, architects, and engineers work with clients across the globe to deliver the highly specialized environments required for their current and planned particle therapy practice. The team has experience with more than 30 planned, design, or built proton/particle therapy centers worldwide.

“We’re excited to welcome Erik to our team,” says John Jessen, AIA, Stantec senior principal and leader of the Particle Therapy Center of Excellence. “He’s been a trusted advisor to many healthcare practices, and is an expert in bringing these very complex centers from concept through commissioning.”

Stantec is a leading expert in the design of particle therapy centers. A dedicated team of experts have worked on world class facilities around the globe, including more than 30 of the centers currently built, or in planning or design. Based in Washington, DC, the firm’s Particle Therapy Center of Excellence professionals develop unique solutions for each client and their sites.


About Stantec
We're active members of the communities we serve. That's why at Stantec, we always design with community in mind. The Stantec community unites approximately 22,000 employees working in over 400 locations across six continents. Our work—engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics, from initial project concept and planning through design, construction, and commissioning—begins at the intersection of community, creativity, and client relationships. With a long-term commitment to the people and places we serve, Stantec has the unique ability to connect to projects on a personal level and advance the quality of life in communities across the globe. Stantec trades on the TSX and the NYSE under the symbol STN. Visit us at stantec.com or find us on social media.

Back to HCB News

Rad Oncology Homepage